Aegon Nv Stock Earnings Reports

Aegon delivered a strong 2025, meeting or exceeding its financial targets and demonstrating clear progress on its strategic shift toward higher‑margin U.S. strategic assets. Key financials: operating results rose 15% year‑on‑year to EUR 1.7 billion, operating capital generation (OCG) before holding/funding costs reached EUR 1.3 billion, and full‑year free cash flow was EUR 829 million (in line with guidance). The board proposed a final dividend of EUR 0.21 (EUR 0.40 full year, +14%), executed EUR 400 million of H2 2025 buybacks and has started the first EUR 400 million tranche of the 2026 buyback program. Commercial momentum in the U.S. was a highlight: World Financial Group (WFG) licensed agents rose to ~96,000 (target ~110,000 by 2027), new life sales increased (notably a 30% increase in Individual Life new life sales) and indexed annuity deposits grew strongly. IFRS CSM for U.S. strategic assets increased materially (24% in H2), and strategic assets now represent a majority of Americas CSM. Capital metrics remain robust (group solvency ~184%, U.S. RBC ~424%) despite the end of eligibility for certain subordinated bonds and one‑off reinsurance-related P&L impacts (SGUL transaction). Management reiterated progress on the planned U.S. redomiciliation and U.S. GAAP implementation (early stages). Areas investors should monitor: volatility from experience/assumption variances (quarterly swings in mortality/morbidity and new business strain), ongoing runoff/management of financial legacy assets (targeting further reduction from USD 2.7bn), long‑term care reserving sensitivity, small upticks in ECL from some downgrades/defaults, and the outcome/timing of the strategic review of Aegon UK.